Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats (Q34236634)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 29, 2011

Language	Label	Description	Also known as
English	Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats	scientific article published on November 29, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Lisbeth Elster

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kristen Frederiksen

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Christoffer Bundgaard

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Anne Techau Bruun

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael Didriksen

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

John P. Redrobe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22124672

18 December 2024

Inge E. M. de Jong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22124672

18 December 2024

Garrick P. Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22124672

18 December 2024

Peter H. Larsen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22124672

18 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22124672

18 December 2024

publication date

29 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00213-011-2593-9.pdf

1 reference

10.1007/S00213-011-2593-9

https://api.crossref.org/works/10.1007/S00213-011-2593-9

18 December 2024

http://link.springer.com/article/10.1007/s00213-011-2593-9/fulltext.html

HyperText Markup Language

1 reference

10.1007/S00213-011-2593-9

https://api.crossref.org/works/10.1007/S00213-011-2593-9

18 December 2024

http://link.springer.com/content/pdf/10.1007/s00213-011-2593-9

1 reference

10.1007/S00213-011-2593-9

https://api.crossref.org/works/10.1007/S00213-011-2593-9

18 December 2024

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

221

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

451-468

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

GABAA Receptor Subtype-Selective Modulators. II. &#945;5-Selective Inverse Agonists for Cognition Enhancement

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

CNTRICS final task selection: executive control

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Extrasynaptic GABAA receptors: form, pharmacology, and function

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

A simple objective technique for measuring flexibility in thinking.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Evaluation of a neurodevelopmental model of schizophrenia--early postnatal PCP treatment in attentional set-shifting.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Recognition memory: material, processes, and substrates

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Translating developmental time across mammalian species.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Memory in schizophrenia: what is impaired and what is preserved?

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Reduced evoked gamma oscillations in the frontal cortex in schizophrenia patients: a TMS/EEG study

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Hippocampal alpha 5 subunit-containing GABA A receptors are involved in the development of the latent inhibition effect.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

On the nature of Wisconsin Card Sorting Test performance in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Executive function in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The visual paired-comparison task as a measure of declarative memory

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Etomidate targets alpha5 gamma-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Which GABAA-receptor subtypes really occur in the brain?

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The pharmacology of the benzodiazepine site of the GABA-A receptor is dependent on the type of gamma-subunit present

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Role of GABAA receptors in cognition

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Reinforcement and reversal learning in first-episode psychosis.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Mutant mouse models: phenotypic relationships to domains of psychopathology and pathobiology in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Subunit composition, distribution and function of GABA(A) receptor subtypes

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Visual perceptual and working memory impairments in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Neurophysiological and Computational Principles of Cortical Rhythms in Cognition

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval.

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach

2 references

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropsychological evidence for frontostriatal dysfunction in schizophrenia

2 references

https://api.crossref.org/works/10.1007/S00213-011-2593-9

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GABAA receptors: subtypes, regional distribution, and function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurodevelopmental consequences of early exposure to phencyclidine and related drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired recognition memory in rats after damage to the hippocampus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term potentiation and cognitive drug discovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3HRY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memory impairment in schizophrenia: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22124672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular Pharmacology

43

44

1211

author name string

KL Hadingham

publication date

1993

1 reference

10.1007/S00213-011-2593-9

https://api.crossref.org/works/10.1007/S00213-011-2593-9

18 December 2024

GABA<SUB>A</SUB> Receptors: Subtypes, Regional Distribution, and Function

73

1 reference

10.1007/S00213-011-2593-9

https://api.crossref.org/works/10.1007/S00213-011-2593-9

18 December 2024

Identifiers

10.1007/S00213-011-2593-9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34236634&oldid=2289246420"